Rural Proofing the National Service Framework for Mental Health
"The Rural Proofing project was funded by NIMHE, in response to the mechanism, introduced in the Government's 2000 Rural White Paper, to assess all major polices for their rural impact and adjustments made. The project was managed by Mind and the National Mental Health Partnership.
The initial intention was to rural proof the English adult NSFMH, however the resulting document is more than that. As we researched the project it became clear that there was no single repository for rural issues that impact on mental health. We have therefore produced a document that has considered not only the adult NSFMH, its Standards and underpinning programmes, the Mental Health Policy Implementation Plan and the NHS Plan, but also other significant issues relevant to rural communities..." - Keith Elder, Rural Minds Development Manager.
Thursday, September 30, 2004
Report from the Center for Economic and Policy Research - "Rising drug prices are placing an ever larger burden on family budgets and the economy. The Center for Medicare and Medicaid Services estimates 2004 expenditures at $207 billion (more than $700 per person), and projects that annual spending will grow to more than $500 billion by 2013 (more than $1,600 per person). The immediate cause of high drug prices is government granted patent monopolies, which allow drug companies to charge prices that are often 400 percent, or more, above competitive market prices. Patent monopolies are one possible mechanism for financing prescription drug research. Rapidly increasing drug costs, and the economic distortions they imply, have led researchers to consider alternative mechanisms for financing drug research. This paper outlines some of the key issues in evaluating patents and other mechanisms for financing prescription drug research. It then assesses how four proposed alternatives to the patent system perform by these criteria."
comment []
Reuters Health story at Yahoo - "Two drugs commonly prescribed for schizophrenia - clozapine and olanzapine -- may carry a small risk of an increased risk of diabetes, new research shows. The study of nearly 57,000 schizophrenia patients in the Veterans Affairs (VA) health system found that just over 7 percent developed diabetes over 1 to 2 years of follow-up. The risk of diabetes was higher among those who were on the antipsychotic drugs clozapine or olanzapine for at least 3 months during the study period. "
comment []
AP story at Yahoo - "The Food and Drug Administration will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants. Dr. Janet Woodcock, acting FDA (news - web sites) deputy commissioner, could not say how long the exhaustive analysis would take or how much it would cost. 'It's a huge undertaking,' Woodcock said Tuesday. Columbia University's analysis of pediatric clinical trial data examined just one-tenth of the information contained in adult databases. "
comment []
Copyright 2003 © Bill Davis.
IIMHL Update is a project done in collaboration with MHCA and the Centre for Community Change International. IIMHL Update is powered by Radio Userland.